Latest stories on ACRV
Acrivon Therapeutics: Priced For Failure, Built For Precision
Seeking Alpha56 · neutralgeneral
Acrivon Therapeutics, Inc. (ACRV) files 8-K
SEC 8-K50 · neutralgeneral
Acrivon Therapeutics to Present at TD Cowen’s 7th Annual Oncology Innovation Summit | ACRV Stock News
StockTitan56 · neutralproduct/pr
ACRV: [Form 4] Acrivon Therapeutics, Inc. Insider Trading Activity
StockTitan SEC50 · neutralgeneral
Acrivon Therapeutics GAAP EPS of -$0.49 beats by $0.03
Seeking Alpha56 · neutralearnings